Alena Ivanova is a Senior Scientist at AstraZeneca, focusing on advanced drug delivery and therapeutic genome editing. They previously held a postdoctoral researcher role at AstraZeneca and conducted research as a PhD student at DKFZ German Cancer Research Center, where they explored the Wnt signaling pathway and identified novel mechanisms related to cell protrusions. Alena participated in an EMBO short-term fellowship at Institut Curie, studying the role of Wnt proteins in extracellular vesicles. They earned a PhD in Life Sciences from Heidelberg University alongside their studies at DKFZ.
This person is not in the org chart
This person is not in any teams
This person is not in any offices